Urachal cancer is a malignancy that arises from the residual tissue of the urachus, which is the embryonic element that connects the bladder to the navel. The urachus is a large part of the development of the urinary system in the fetus, but after birth, its remnants usually disappear or are transformed into fibrous cords. Pathological changes in these tissues can lead to urachus cancer, which is a rare but potentially serious condition. This type of tumor is most often detected in men and in older people, which sometimes makes it difficult to diagnose in a timely manner, since symptoms in the early stages can be subtle. It is important to note that urachus cancer is usually associated with other cancers, such as bladder cancer.
History of the disease and interesting historical facts
The history of the study of urachus cancer covers many aspects, starting with the first descriptions of malignant tumors in ancient times. More detailed attention to this disease arose in the 20th century, when modern diagnostic and treatment methods began to be introduced. In the 1970s, doctors began to record an increasing number of cases of urachus cancer associated with changes in lifestyle and environmental conditions. One of the interesting facts of history is that urachus cancer was initially considered an exceptionally tolerant tumor of the bladder, and only at the end of the 20th century, thanks to research, it became clear that this is a separate disease with its own course and characteristics.
Epidemiology
Urachal cancer is considered a rare disease. According to medical statistics, its frequency ranges from 0.5 to 2% among all cases of bladder cancer. Only about 200-300 new cases of this disease are recorded annually in the world. In most cases, urachus cancer is diagnosed in men aged 40 to 70 years, which may be due to environmental conditions and some social factors, such as smoking. It is noteworthy that cases among women are less common, which also requires further study and analysis.
Genetic predisposition to this disease
Research suggests that genetic susceptibility to urachal cancer may be linked to certain genes involved in cell cycle and apoptosis regulation. In particular, mutations in genes such as TP53 and KRAS have been associated with an increased risk of urogenital malignancies. Population studies also suggest possible links to a family history of pelvic tumors, highlighting the importance of genetic testing for early diagnosis.
Risk factors for the development of this disease
There are various factors that contribute to the development of urachus cancer, among which the following can be distinguished:
- Smoking: Nicotine and other carcinogens found in tobacco smoke can promote mutations in urachus cells.
- Chemical exposures: Exposure to certain chemicals, such as aromatic amines, has been identified as a risk factor.
- Infectious diseases: Some studies have linked urachus cancer to infections such as CPT (chlamydial infection).
- Background diseases: The presence of other malignant processes, especially in the genitourinary system.
- Ethnicity: Some ethnic groups have a higher risk, which may be due to a predisposition.
Diagnosis of this disease
Diagnosis of urachus cancer requires a comprehensive approach and includes the following:
- Main symptoms: Signs of urachus cancer may include blood in the urine, lower abdominal pain, frequent urge to urinate, and unexplained weight loss.
- Laboratory tests: The examination includes a urine test to detect cancer cells and a blood chemistry test to evaluate kidney and bladder function.
- Radiological examinations: Ultrasound, CT and MRI of the abdominal organs help to identify tumors and assess their size and stage.
- Other diagnostic tests: Cystoscopy, biopsy of urachus tissue and nodes may be necessary to confirm the diagnosis.
- Differential diagnosis: It is important to differentiate urachus cancer from other diseases such as infectious processes, benign tumors and other malignant neoplasms.
Treatment
Treatment of urachus cancer is usually complex and includes various approaches:
- General treatment: Treatment may include courses of chemotherapy, radiation therapy, and immunotherapy depending on the stage of the disease.
- Pharmacological treatment: Use of specific antitumor drugs such as Cisplatin and Mitomycin.
- Surgical treatment: Tumor resection with possible cystectomy and mobilization of surrounding tissues.
- Other treatments: In some cases, palliative care may be considered to improve the quality of life of patients with terminal cancer.
List of medications used to treat this disease
The list of drugs used for chemotherapy and treatment of urachus cancer includes:
- Cisplatin
- Mitomycin
- Doxorubicin
- Gemcitabine
- Paclitaxel
- Moxatin
- Trastuzumab
Disease monitoring
Urachal cancer monitoring includes regular examinations and assessment of the patient's condition. Monitoring is planned at the following stages:
- Follow-up: After treatment, regular visits to the oncologist, laboratory tests and imaging are required every 3-6 months for the first two years.
- Prognosis: The prognosis depends on the stage of the disease at the time of diagnosis, the histological type of the tumor and the general health of the patient.
- Complications: Possible complications include recurrent tumors, metastases to surrounding tissues and organs, and the need for additional surgeries or symptomatic therapy.
Age-related features of the disease
Urachal cancer can manifest itself differently in different age groups. Older people usually have more pronounced symptoms and late stages at the time of diagnosis. In young people, this disease is extremely rare, but if it occurs, it can be aggressive due to more active metabolic processes. Isolated cases have been recorded in children, often as congenital anomalies.
Questions and Answers
- What is urachus cancer? Urachal carcinoma is a malignant tumor that arises from residual tissues of the urachus, which is part of the embryonic development of the urinary system.
- What are the main causes of urachus cancer? Major risk factors include smoking, exposure to chemical carcinogens, and infectious diseases.
- How is urachus cancer diagnosed? Diagnosis includes urine tests, radiological examinations and tissue biopsy, in addition, it is important to conduct a differential diagnosis to exclude other diseases.
- How is urachus cancer treated? Treatment may include surgery, chemotherapy, and radiation therapy, depending on the stage of the disease.
- What is the prognosis for patients with urachus cancer? The prognosis depends on the stage at diagnosis and the patient's general health, but generally the earlier treatment is started, the better the outcome.
